Retroperitoneal Lymph Node Dissection in Testicular Cancer

Niels Erik B Jacobsen, Richard Foster, John P. Donohue

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

With long-term survival in excess of 90% across all stages, testicular cancer has come to represent the model for successful multidisciplinary cancer care. Retroperitoneal lymph node dissection (RPLND) remains an integral component of testis cancer management strategies for both early- and advanced-stage disease. Commensurate with improvements made in clinical staging and in our understanding of the natural history of testis cancer, lymphatic spread, and neuroanatomy, considerable modifications in the technique and template of RPLND have taken place. The morbidity of primary RPLND and postchemotherapy RPLND is low when performed by experienced surgeons. This article reviews the evolution, role, and technique of RPLND in contemporary practice.

Original languageEnglish
Pages (from-to)199-220
Number of pages22
JournalSurgical Oncology Clinics of North America
Volume16
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Testicular Neoplasms
Lymph Node Excision
Neuroanatomy
Morbidity
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Retroperitoneal Lymph Node Dissection in Testicular Cancer. / Jacobsen, Niels Erik B; Foster, Richard; Donohue, John P.

In: Surgical Oncology Clinics of North America, Vol. 16, No. 1, 01.2007, p. 199-220.

Research output: Contribution to journalArticle

Jacobsen, Niels Erik B ; Foster, Richard ; Donohue, John P. / Retroperitoneal Lymph Node Dissection in Testicular Cancer. In: Surgical Oncology Clinics of North America. 2007 ; Vol. 16, No. 1. pp. 199-220.
@article{f8e2467102654c6c95e3dae3362d03ad,
title = "Retroperitoneal Lymph Node Dissection in Testicular Cancer",
abstract = "With long-term survival in excess of 90{\%} across all stages, testicular cancer has come to represent the model for successful multidisciplinary cancer care. Retroperitoneal lymph node dissection (RPLND) remains an integral component of testis cancer management strategies for both early- and advanced-stage disease. Commensurate with improvements made in clinical staging and in our understanding of the natural history of testis cancer, lymphatic spread, and neuroanatomy, considerable modifications in the technique and template of RPLND have taken place. The morbidity of primary RPLND and postchemotherapy RPLND is low when performed by experienced surgeons. This article reviews the evolution, role, and technique of RPLND in contemporary practice.",
author = "Jacobsen, {Niels Erik B} and Richard Foster and Donohue, {John P.}",
year = "2007",
month = "1",
doi = "10.1016/j.soc.2006.10.003",
language = "English",
volume = "16",
pages = "199--220",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Retroperitoneal Lymph Node Dissection in Testicular Cancer

AU - Jacobsen, Niels Erik B

AU - Foster, Richard

AU - Donohue, John P.

PY - 2007/1

Y1 - 2007/1

N2 - With long-term survival in excess of 90% across all stages, testicular cancer has come to represent the model for successful multidisciplinary cancer care. Retroperitoneal lymph node dissection (RPLND) remains an integral component of testis cancer management strategies for both early- and advanced-stage disease. Commensurate with improvements made in clinical staging and in our understanding of the natural history of testis cancer, lymphatic spread, and neuroanatomy, considerable modifications in the technique and template of RPLND have taken place. The morbidity of primary RPLND and postchemotherapy RPLND is low when performed by experienced surgeons. This article reviews the evolution, role, and technique of RPLND in contemporary practice.

AB - With long-term survival in excess of 90% across all stages, testicular cancer has come to represent the model for successful multidisciplinary cancer care. Retroperitoneal lymph node dissection (RPLND) remains an integral component of testis cancer management strategies for both early- and advanced-stage disease. Commensurate with improvements made in clinical staging and in our understanding of the natural history of testis cancer, lymphatic spread, and neuroanatomy, considerable modifications in the technique and template of RPLND have taken place. The morbidity of primary RPLND and postchemotherapy RPLND is low when performed by experienced surgeons. This article reviews the evolution, role, and technique of RPLND in contemporary practice.

UR - http://www.scopus.com/inward/record.url?scp=33847296297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847296297&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2006.10.003

DO - 10.1016/j.soc.2006.10.003

M3 - Article

C2 - 17336244

AN - SCOPUS:33847296297

VL - 16

SP - 199

EP - 220

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -